Tevagastrim®
ACTIVE PRINCIPLE:
Filgastrim
INDICATION:
Neutropenia in the context of oncological processes
Hematopoietic stem cell transplantation
DATE:
07/12/2009
STATUS:
Authorized
ACTIVE PRINCIPLE:
Filgastrim
INDICATION:
Neutropenia in the context of oncological processes
Hematopoietic stem cell transplantation
DATE:
07/12/2009
STATUS:
Authorized